CA
BCPC

Continuum Advisory’s Balchem Corp BCPC Stock Holding History

Continuum Advisory’s Portfolio BCPC Stock Details BCPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$354 – 1978
2024
Q3 		$354 Hold
2
– – ﹤0.01% 1841
2024
Q2 		$308 Hold
2
– – ﹤0.01% 1663
2024
Q1 		$310 Buy
+2
New +$297 ﹤0.01% 1655

Other funds holding BCPC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Continuum Advisory's BCPC Position: Q4 2024 in Review

Continuum Advisory sold out of Balchem Corp (BCPC) in Q4 2024, closing a stake of 2 shares — an estimated $354 sold.

Continuum Advisory first reported a position in BCPC in Q1 2024 and held it in 3 quarters. The position peaked at $354 in Q3 2024. 359 funds tracked by Wall St. Rank hold BCPC as of Q4 2024.

  • Continuum Advisory reported no remaining Balchem Corp position as of Q4 2024 after selling out during the quarter.
  • Continuum Advisory sold 2 Balchem Corp shares in Q4 2024, an estimated $354.
  • Continuum Advisory first reported a position in Balchem Corp in Q1 2024 and held it in 3 quarters.
  • Continuum Advisory's Balchem Corp position peaked at $354 in Q3 2024.
  • 359 funds tracked by Wall St. Rank held Balchem Corp as of Q4 2024.

Based on Continuum Advisory's 13F filing for Q4 2024, filed 18 Feb 2025.